WallachBeth Capital Facilitates Tenon Medical's Warrant Inducement Raising Nearly $2.9 Million

WallachBeth Capital's Strategic Move for Tenon Medical

On September 11, 2026, WallachBeth Capital LLC, a prominent player in capital markets and institutional execution services, announced a significant warrant inducement transaction involving Tenon Medical, Inc. (NASDAQ: TNON). This initiative aims to bolster Tenon Medical's resources in the medical device sector, particularly for treating sacro-pelvic disorders.

The Details of the Transaction

The warrant inducement involves an agreement with an institutional investor to encourage the exercise of existing warrants related to Tenon Medical's shares. Specifically, the agreement pertains to approximately 572,179 shares of common stock under the Existing Warrants, with the exercise expected to yield gross proceeds of approximately $2,872,338.58.

In exchange for the immediate execution of the Existing Warrants, the investor would receive new, unregistered warrants, termed as the New Warrants, permitting them to buy up to 858,269 shares of common stock at an exercise price of $5.02 per share. This represents a generous 150% increase based on the shares obtained from the Existing Warrants. These New Warrants are designed to be immediately exercisable, with a validity spanning five years from their issue date.

Anticipated Closing and Financial Implications

The transaction is expected to close around September 14, 2026, subject to standard closing conditions. Overall, the financial advisors at WallachBeth Capital foresee that the gross yield from this warrant transaction will significantly enhance Tenon Medical's capital, providing it with a key financial boost as it navigates the competitive landscape of medical technologies. Notably, this amount excludes any additional funds that may arise from the exercise of the New Warrants or expenses incurred during the transaction.

The Role of WallachBeth Capital

WallachBeth Capital's role in facilitating this agreement underscores its commitment to providing extensive capital markets and investment banking services, particularly within the healthcare industry. With a repertoire that includes initial public offerings, PIPE (Private Investment in Public Equity) offerings, and various private transactions, the firm is positioned as a vital partner for healthcare corporations aiming to meet their financial objectives.

The firm’s deep understanding of the capital markets allows it to align financial strategies closely with client needs, ultimately aiding in the evolution of healthcare solutions.

Forward-Looking Statements

As with all financial announcements, this transaction includes forward-looking statements, with Tenon Medical projecting timelines, conditions, and potential outcomes related to the offering. The future remains uncertain, and investors are encouraged to review Tenon's Annual Report on Form 10-K for detailed insights into the Company's financial positioning and risk factors.

In conclusion, the successful execution of this warrant inducement not only strengthens Tenon Medical’s financial foundation but also positions it advantageously within the healthcare sector, where the demand for innovative and effective medical solutions continues to grow. The backing from WallachBeth Capital enhances the Company’s potential to expand its offerings and ultimately improve patient care in conditions like sacro-pelvic disorders.